Chargement en cours...
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen in the World and there is an urgent need for a vaccine to prevent these infections. To determine what type of adjuvant can better enhance the immunogenicity of a Chlamydia vaccine, we formulated the recombinant maj...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3156873/ https://ncbi.nlm.nih.gov/pubmed/21742006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.06.105 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|